EyePoint Pharmaceuticals, Inc. (EYPT): Price and Financial Metrics
EYPT Price/Volume Stats
| Current price | $7.48 | 52-week high | $30.99 |
| Prev. close | $7.27 | 52-week low | $6.90 |
| Day low | $7.15 | Volume | 564,800 |
| Day high | $7.52 | Avg. volume | 864,009 |
| 50-day MA | $8.68 | Dividend yield | N/A |
| 200-day MA | $10.43 | Market Cap | 510.52M |
EYPT Stock Price Chart Interactive Chart >
EyePoint Pharmaceuticals, Inc. (EYPT) Company Bio
EyePoint Pharmaceuticals (formerly pSivida Corp.) develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company was founded in 1987 and is based in Watertown, Massachusetts.
EYPT Price Returns
| 1-mo | 5.35% |
| 3-mo | -30.42% |
| 6-mo | -18.34% |
| 1-year | -66.49% |
| 3-year | -14.42% |
| 5-year | -53.54% |
| YTD | 0.40% |
| 2024 | -67.76% |
| 2023 | 560.29% |
| 2022 | -71.41% |
| 2021 | 86.02% |
| 2020 | -57.55% |
Continue Researching EYPT
Here are a few links from around the web to help you further your research on EyePoint Pharmaceuticals Inc's stock as an investment opportunity:EyePoint Pharmaceuticals Inc (EYPT) Stock Price | Nasdaq
EyePoint Pharmaceuticals Inc (EYPT) Stock Quote, History and News - Yahoo Finance
EyePoint Pharmaceuticals Inc (EYPT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...